Chemomics and drug innovation

被引:0
|
作者
XU Jun [1 ]
GU Qiong [1 ]
LIU HaiBo [2 ]
ZHOU JiaJu [1 ]
BU XianZhang [1 ]
HUANG ZhiShu [1 ]
LU Gui [1 ]
LI Ding [1 ]
WEI DongQing [3 ]
WANG Ling [1 ]
GU LianQuan [1 ]
机构
[1] Research Center for Drug Discovery (RCDD),School of Pharmaceutical Sciences and Institute of Human Virology,Sun Yat-Sen University
[2] Institute of Medicinal Plant Development,Peking Union Medical College,Chinese Academy of Medical Sciences
[3] Biostatistics College of Life Sciences and Biotechnology,Shanghai Jiaotong
关键词
D O I
暂无
中图分类号
R284 [中药化学];
学科分类号
摘要
Chemomics is an interdisciplinary study using approaches from chemoinformatics,bioinformatics,synthetic chemistry,and other related disciplines.Biological systems make natural products from endogenous small molecules (natural product building blocks) through a sequence of enzyme catalytic reactions.For each reaction,the natural product building blocks may contribute a group of atoms to the target natural product.We describe this group of atoms as a chemoyl.A chemome is the complete set of chemoyls in an organism.Chemomics studies chemomes and the principles of natural product syntheses and evolutions.Driven by survival and reproductive demands,biological systems have developed effective protocols to synthesize natural products in order to respond to environmental changes;this results in biological and chemical diversity.In recent years,it has been realized that one of the bottlenecks in drug discovery is the lack of chemical resources for drug screening.Chemomics may solve this problem by revealing the rules governing the creation of chemical diversity in biological systems,and by developing biomimetic synthesis approaches to make quasi natural product libraries for drug screening.This treatise introduces chemomics and outlines its contents and potential applications in the fields of drug innovation.
引用
收藏
页码:71 / 85
页数:15
相关论文
共 50 条
  • [1] Chemomics and drug innovation
    Xu Jun
    Gu Qiong
    Liu HaiBo
    Zhou JiaJu
    Bu XianZhang
    Huang ZhiShu
    Lu Gui
    Li Ding
    Wei DongQing
    Wang Ling
    Gu LianQuan
    SCIENCE CHINA-CHEMISTRY, 2013, 56 (01) : 71 - 85
  • [2] Chemomics and drug innovation
    XU Jun
    GU Qiong
    LIU HaiBo
    ZHOU JiaJu
    BU XianZhang
    HUANG ZhiShu
    LU Gui
    LI Ding
    WEI DongQing
    WANG Ling
    GU LianQuan
    Science China(Chemistry), 2013, (01) : 71 - 85
  • [3] Chemomics and drug innovation
    Jun Xu
    Qiong Gu
    HaiBo Liu
    JiaJu Zhou
    XianZhang Bu
    ZhiShu Huang
    Gui Lu
    Ding Li
    DongQing Wei
    Ling Wang
    LianQuan Gu
    Science China Chemistry, 2013, 56 : 71 - 85
  • [4] Innovation in drug development
    Szelejewski, Wieslaw
    Kutner, Andrzej
    PRZEMYSL CHEMICZNY, 2012, 91 (03): : 255 - 262
  • [5] Innovation in Drug Development
    Vogenberg, F. Randy
    AMERICAN HEALTH AND DRUG BENEFITS, 2009, 2 (02): : 69 - 69
  • [6] DRUG INNOVATION BUREAUCRACY
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1980, 280 (6230): : 1484 - 1485
  • [7] DRUG LICENSING OR INNOVATION
    不详
    LANCET, 1981, 2 (8250): : 788 - 788
  • [8] DRUG INNOVATION IN BRITAIN
    SMITH, R
    BRITISH MEDICAL JOURNAL, 1988, 297 (6657): : 1152 - 1152
  • [9] Drug innovation on the decline
    Young, Donna
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (03) : 228 - +
  • [10] Introduction : promotion of open innovation for drug innovation
    Akaike, Akinori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S12 - S12